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LETTERS TO THE EDITORRegarding “Gait variability is altered in patients with
peripheral arterial disease”
We would like to provide comment on research recently pub-
lished in the Journal of Vascular Surgery entitled “gait variability is
altered in patients with peripheral arterial disease” by Myers et al.1 The
Myers et al (2009) study complements previous work from our
group.2-4 These studies suggest that patients who have peripheral
arterial disease (PAD) display reduced temporal-spatial gait parame-
ters and increased linear movement variability in the lower limbs
compared with health, age, and mass matched controls. These gait
abnormalities do not improve following a 12-month supervised exer-
cise program despite increases in pain free walking distance.5
Myers et al suggest that an increase in movement variability, as
assessed via the Lyapunov exponent, indicates increased instability and
a potential greater risk of falls in this population. While this conclusion
is interesting we would suggest that an increase in movement variabil-
ity is a gait response to the pending onset of claudication pain and may
not reflect a potential for increased fall risk.
Traditionally, movement variability has been viewed as “noise”
representing random fluctuations that should be controlled or re-
duced. However, research using the dynamic system perspective has
provided a new way of viewing movement variability. It is now
thought that movement variability may be of functional impor-
tance in motor control, and it may provide flexibility when adjust-
ing to perturbations in the environment.6
Movement variability should not necessarily be viewed as
something that should be controlled in clinical treatment. Rather
movement variability may be beneficial or an adaptive mechanism.
We appreciate the excellent research study of Myers et al (2009)
but conclude that higher or lower movement variability is currently
of unclear significance. More research is needed to determine the
levels of movement variability in different disease states and its
beneficial or detrimental influence on gait.
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The points raised by Crowther et al, deserve a closer evalua-
tion. Both our group and Crowther et al studied symptomatic
peripheral arterial disease (PAD) patients. However, significant
methodologic differences exist between the publications. Specifi-
cally, it is established in the gait literature that 30 strides are
required for an accurate measurement of gait variability and that
determination of both amount (ie, standard deviations) and struc-
ture (ie, largest Lyapunov Exponent) of gait variability are neces-
sary for its complete and optimal description as per our protocol.1,2
In contrast, Crowther et al assessed variability on the basis of three,
one-stride trials and were able to calculate only the amount of
variability.
Our assertion that an increase in the amount and structure of
variability is an indicator of increased instability and a potential risk
factor for falls is not a novel one. In fact, this conclusion has been
reached by our lab and several others after years of work on gait
variability in elderly and other populations with gait impairments.3
Dr. Crowther’s suggestion that increased variability may be “a gait
response to the pending onset of claudication pain” incorrectly
characterizes the methodology used in our article and contradicts
what has been shown in the literature. In our study,1 gait variability
was measured in a pain-free state (no pain or fatigue). More
importantly, our work evaluating lower limb function using ad-
vanced biomechanical analysis demonstrates that the gait impair-
ment of PAD patients is present from the initial steps they take
when no pain or anticipation of pain could be present,1,4 This is
consistent with previous work from our lab and others demonstrat-
ing a myopathy and neuropathy in the limbs of PAD patients.5
Finally, even if patients were able to anticipate the onset of claudi-
cation, it is unlikely that they would employ changes that increase
variability as it has been previously shown that when subjects
anticipate a stimulus, their locomotor system becomes more rigid
and has a decreased amount of variability,6 which is the opposite of
what we have found in PAD patients. We agree with the dynamical
systems perspective of variability, which states that movement
variability allows individuals to adapt to perturbations in the envi-
ronment. The beneficial effect of variability, however, is limited.
An increase or decrease past an optimal range of variation has a
detrimental effect on movement,7 and this point is clearly discussed
in the dynamical systems article cited to support the authors’ point.
As discussed in our article,1 a healthy locomotor system pos-
sesses a specific amount of variability having form and a complex
deterministic structure.7 Deviations from this optimal level are
detrimental and clinically significant, and the goal of clinical treat-
ment should be to restore an optimal amount and form of variabil-
ity.7 Our data is in line with Dr Crowther’s group and demonstrate
that symptomatic PAD patients have increased gait variability at
baseline ambulation in the absence of claudication pain indicating
decline of the overall health of the PAD locomotor system. This
deterioration results in increased noise and instability of gait and is
a potential contributing factor to the falls and mobility problems
experienced by symptomatic PAD patients.
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